Skip to main content

Table 7 Pregnancy outcome after embryo transfer by absolute value of AMH according to patient age

From: Age-specific definition of low anti-Mullerian hormone and associated pregnancy outcome in women undergoing IVF treatment

 

Age of patients < 35

P value

Embryo transfer with AMH ≥ 1.0 ng/ml (n = 576)

Embryo transfer with AMH < 1.0 ng/ml (n = 38)

Positive hCG per transfer

62.5% (360/576)

42.1% (16/38)

0.012

Positive hCG per D3 embryo transfer

62.5% (283/453)

35.5% (15/36)

0.014

Positive hCG per blastocyst transfer

62.6% (77/123)

50% (1/2)

1.00

Biochemical pregnancy per transfer

4.9% (28/576)

2.6% (1/38)

1.00

Ectopic pregnancy per transfer

0.9% (5/576)

0

1.00

Clinical pregnancy per transfer

56.8% (327/576)

39.5% (15/38)

0.038

Miscarriage per clinical pregnancy

9.2% (30/327)

20% (3/15)

0.167

Ongoing pregnancy per transfer

51.6% (297/576)

31.6% (12/38)

0.017

Ongoing pregnancy per D3 embryo transfer

50.8% (230/453)

30.6% (11/36)

0.02

Ongoing pregnancy per blastocyst transfer

54.5% (67/123)

50% (1/2)

1.00

 

Age of patients≥35

 

Embryo transfer with AMH ≥ 1.0 ng/ml (n = 326)

Embryo transfer with AMH < 1.0 ng/ml (n = 68)

Positive hCG per transfer

49.1% (160/326)

26.5% (18/68)

0.001

Positive hCG per D3 embryo transfer

46.5% (119/256)

27.7% (18/65)

0.006

Positive hCG per blastocyst transfer

58.6% (41/70)

0 (0/3)

0.08

Biochemical pregnancy per transfer

4.3% (14/326)

4.4% (3/68)

1.00

Clinical pregnancy per transfer

44.8% (146/326)

22.1% (15/68)

0.001

Miscarriage per clinical pregnancy

17.1% (25/146)

26.7% (4/15)

0.573

Ongoing pregnancy per transfer

34.1% (121/326)

16.2% (11/68)

0.001

Ongoing pregnancy per D3 embryo transfer

34.0% (87/256)

16.9% (11/65)

0.008

Ongoing pregnancy per blastocyst transfer

48.6% (34/70)

0 (0/3)

0.243